Motivation: Metabolic profiles derived from high resolution 1 H-NMR data are complex, therefore statistical and machine learning approaches are vital for extracting useful information and biological insights. Focused modelling on targeted subsets of metabolites and samples can improve the predictive ability of models, and techniques such as genetic algorithms (GAs) have a proven utility in feature selection problems. The Consortium for Metabonomic Toxicology (COMET) obtained temporal NMR spectra of urine from rats treated with model toxins and stressors. Here, we develop a GA approach which simultaneously selects sets of samples and spectral regions from the COMET database to build robust, predictive classifiers of liver and kidney toxicity.
INTRODUCTION
Many machine learning techniques have been used to delve deeper into the large and complex datasets generated by 'omics' technologies. A crucial theme in the analysis of 'omics' data is the production of accurate models that not only predict or classify well, but also enhance biological understanding. Metabolic profiling [metabolomics (Fiehn, 2002) and metabonomics (Nicholson et al., 1999) ] is one such technology which probes the metabolic state of organisms through monitoring metabolite levels in cells, biofluids * To whom correspondence should be addressed. and tissues. The profiles are typically generated by nuclear magnetic resonance (NMR) spectroscopy or mass spectrometry, which are able to assay hundreds to thousands of metabolites at a single pass. In a typical metabonomic experiment, metabolic profiles from normal and abnormal animals are obtained and multivariate statistical models are built with the aim of distinguishing the groups (Keun and Athersuch, 2007; Nicholson et al., 2002) . One of the prerequisites for biological interpretation of these models is the definition of which biological samples and metabolic variables, for example regions of the NMR spectrum, are important to the distinction between groups (Holmes et al., 1992) .
Biological datasets derived from modern 'omics' technologies will contain thousands of variables, many of which will have no relevance to the model being built. This property can confound many conventional algorithms for model construction. Selection of a subset of variables can improve the performance of techniques which are inherently able to deal with high-dimensional data, such as principal component analysis and partial least squares discriminant analysis (Alsberg et al., 1998; Hoskuldsson, 2001 ). An additional benefit of variable selection is the simplification of the model, facilitating the identification of important pathways and understanding integrated system function.
It is important to note that the algorithm used for selection of variables can be independent of the algorithm used for classification. Many criteria for variable selection have been proposed (Alsberg et al., 1998; Hoskuldsson, 2001 ). An approach which shows much promise is the use of a genetic algorithm (GA) to pick the variables relating to class differentiation (Broadhurst et al., 1997; Cho and Hermsmeier, 2002; Jarvis and Goodacre, 2005) . GAs are a common machine learning technique (Holland, 1992) , and operate by evolving fixed length (usually) binary strings, called 'chromosomes', which represent solutions to the problem. With GAs the importance of a given variable in the classification problem is usually assessed by its frequency of selection in 'good' solutions over many runs of the algorithm.
In comparison with variable selection, the choice of subsets of samples for model building has received less attention. Much work has been associated with two-mode clustering (or biclustering). For instance, Hageman et al. (2008) used a GA for biclustering of metabolomic data and this clustering technique has been used widely elsewhere on 'omics' datasets (Madeira and Oliveira, 2004) .
Unsupervised clustering based on both samples and variables is fundamentally different from the supervised classification task tackled here, since rather than trying to group samples and variables which show a similar profile, we are interested only in detecting those whose profile helps us to distinguish between the classes. Identification of prototypical samples which influence a classification model can help delineate the biology of interest by simplifying the model. A second advantage of sample selection is the automatic detection and rejection of outlying samples. Outliers are a ubiquitous feature of biological data and their recognition and treatment can be time consuming and complex, especially for large multivariate datasets. A further motivation for implementing sample selection is to reduce computation time. By building models with a small subset of samples, calculations relying on all selected samples (e.g. distance matrices) are accelerated. This is of particular importance when constructing models with stochastic techniques, such as GAs, which build and test many different models throughout the course of a single run.
In metabonomic toxicology, classification models are important in understanding the metabolic characteristics of toxic states in relation to site, severity and mechanism of a lesion (Ebbels et al., 2007) . In a typical study, animals are treated with various compounds and their metabolic profiles compared in order to detect common features across each different type of toxicity (Anthony et al., 1995; Ebbels et al., 2007; Gartland et al., 1991) . These features can then serve as potential biomarkers for toxicity, as well as allowing more in depth exploration of the mechanisms involved. The Consortium for Metabonomic Toxicity (COMET) (Lindon et al., 2005) has exploited this approach by building a substantial temporal metabolic database (n ≈ 30 000) of NMR spectra of urine from rats and mice treated with model toxins and other stressors.
Variable and sample selection approaches could potentially improve interpretation of these datasets aiding the discovery of novel biomarkers of toxicity. However, to date, there have been few investigations of algorithms which use both approaches, either simultaneously or sequentially. This work presents a method for performing simultaneous variable and sample selection using a GA. The method is tested by building predictors of organ toxicity from the metabonomic data in the COMET database. The models are evaluated by their predictive accuracy on an independent test set, and the time taken to construct the models. To achieve greater biological interpretability, we combined data from multiple evolved solutions and developed novel visualization techniques to aid interpretation. All the methods presented could be applied to any multivariate or omics dataset to enrich understanding of the underlying system.
SYSTEM AND METHODS

Sample collection and NMR spectroscopy
In this work, we use a 29 study subset of the full COMET database, selected to exemplify a diverse range of liver and kidney toxicities, avoiding studies exhibiting complex or multi-organ effects. The full study design and protocols are presented elsewhere (Ebbels et al., 2007; Lindon et al., 2005) . Briefly, in each study 8-10 week old Sprague-Dawley rats were randomly divided into controls, low-dose and high-dose groups, with 10 animals per group. Only data from the high-dose group are used in this article. Urine samples were collected from each animal at 16 h pre-dose, 0 h, 8 h, 24 h, 48 h, 72 h, 96 h, 120 h, 144 h and 168 h after dosing. Half the animals from each group were sacrificed at 48 h post-dose with the remainder sacrificed at the end of the study for histopathology and clinical chemistry examination.
Urine samples were mixed with phosphate buffer containing a chemical shift reference [3-(trimethylsilyl) propionic-2,2,3,3-d4 acid sodium salt (TSP)] and sodium azide prior to 1 H NMR spectroscopy (Beckonert et al., 2007) . Spectra were acquired at 600 MHz and 300K on a flowinjection system using a standard one-dimensional pulse sequence including suppression of the water resonance. The 90 • pulse length was ∼10 µs and shims were optimized using gradient shimming. All spectra were then subject to visual inspection and samples with gross shimming artefacts were excluded from further analysis. The spectra were collected into 64K data points using a spectral width of 20 p.p.m. A discretional target was set at <2.5 Hz half-height TSP line width with 1 Hz line broadening. The total acquisition time was ∼4 min per sample. For further details of the NMR procedures, see Keun et al. (2002) .
Data pre-processing
An exponential line broadening factor of 1 Hz was applied prior to Fourier transformation. Spectra were phased, baseline corrected and referenced to TSP using an in-house routine written in MATLAB (The MathWorks, Natick, MA). Each spectrum was reduced to 245 variables by integrating the spectral intensity in regions of equal width (0.04 p.p.m.) over the range 0.2-10.0 p.p.m. This simplifies the data analysis, affords tolerance to line shape imperfections and reduces the impact of small variations in pH or ionic strength on peak positions. In addition, several spectral regions were excluded from the analysis; the region δ (4.50-5.98) was deleted to remove any spurious effects of variability in the suppression of the water resonance and any cross-saturation effects on the urea signal, resulting in 205 integral spectral regions to be used as variables. All spectra were normalized to constant total intensity. In specific studies, drug metabolite signals were removed and treated as missing to minimize the variation which was not due to changes in endogenous metabolite concentrations.
Description of training and test sets
The selected studies exhibited a variety of liver and kidney toxicities including steatosis, necrosis, apoptosis and choleostasis in the liver and cortical and medullary/papillary lesions in the kidney.
Since many of the studies included samples from before the onset or after recovery from the toxic insult, only time points where more the 50% of the animals showed a response according to an in-house model of normal rat urine were used (Ebbels et al., 2007) . It is important to note that this still left many samples which showed a 'normal' profile, since some animals presented a faster, slower or weaker response than the average response for a particular treatment. According to these criteria, each study contributed between 10 and 55 samples to the dataset.
The 29 studies were assigned into training and test sets, maintaining the balance in each set between toxins targeting each organ. We ensured that all samples from a study were in the same set in order to mimic real usage, with data from a toxin of unknown effect being predicted. The training set was deliberately chosen to be much smaller than the test set in order to fully test the generalizability of each of the final solutions. This meant that whilst it contained a range of different toxicities it did not contain examples of all the toxicities seen in the test set. The training set included six studies. Three of liver toxicants: allyl alcohol (20 samples), aflatoxin (10) and rotenone (39) and three of kidney toxicants: mercury chloride (55), maleic acid (30) and aurothiomalate (55), giving a training set comprised of 205 variables and 209 samples. The remaining 23 studies (660 samples) were placed in the test set.
Genetic algorithm
The GA software and predictive classifier were written in-house in MATLAB running on a Mac Pro with 2 × 2.66 GHz Dual-Core Intel Xeon processors and 8 GB 667 MHz DDR2 FV-DIMM RAM. Evaluation of classifier 
accuracy during each GA run was performed using a study-wise leave-oneout cross-validation. The variables and samples selected by the GA were applied to a simple nearest neighbour (NN) algorithm for classification. The samples from each training set study were taken for classification, in turn, excluding those being classified from the selected samples in the training set.
We compared the simultaneous sample and variable selection results to that from the same GA approach but where each method was used individually, or in sequence. The basic algorithm and parameters for the GA used in this work are shown (Table 1) . Begin Create initial population − Each individual solution is made up of two fixed length strings, with each bit set to 1 with probability P i . Repeat Test all solutions − assess the predictive accuracy of the nearest neighbour classifier, using only those samples and variables selected by the solution (corresponding to 1s in each string) using study-wise leave-one-out cross validation. This is their fitness. Repeat Tournament selection − Pick four solutions from the population at random, compare their fitness, save the winning solution and repeat to select a second 'parent'. Crossover − Taking the two winning solutions, pick at random a crossover point inside them. Create a child solution from these two parents by taking the chromosome from one parent up until the crossover point, and from the second parent after the crossover point until the end of the chromosome. Mutation − For each point in the chromosome with probability P m , pick that point to mutate. Until the new population is full.
Until K generation have been simulated.
End
The figure of 250 generations was obtained by performing a number of longer runs and observing when the evolution had typically converged, so little or no further improvement was gained.
The standard GA mutation operator simply changes a bit from 0 to 1 or vice versa. However, this mutation operator has some inherent shortcomings in this context. Since our aim was to evolve simple solutions, the initial population of chromosomes were been initialized so that they, on average, contain 10% 1's (by setting P i to be 0.1). Therefore, the probability that the locus chosen for mutation corresponds to 0 was much higher than the opposite situation. Thus, the use of the standard operator lead to more complex solutions (higher fraction of 1's) over the course of the run.
To counteract this growth a new mutation operator was developed. The locus to be mutated is picked in the normal way. The selected locus is then set to 1 with probability equal to the fraction of 1's in the entire chromosome. One consequence of the new operator is that a selected locus may not change state, slightly decreasing the efficiency of the process, and therefore requiring a higher mutation rate in order to preserve the same number of state changes. However, the new operator consistently retained the simplicity of the solutions leading to higher quality final solutions and was therefore used throughout the work presented here.
Several GA practitioners have found that utilizing multiple chromosomes is a useful way of splitting a problem up into its constituent parts (Hillis, 1990; Hinterding, 1997; Walker et al., 2006) . Here, we implemented a two chromosome solution, so as to have one chromosome for variable selection and a second for sample selection. The only alteration to the basic algorithm needed was that crossover now happens once per chromosome, and an additional choice needs to be made as to which parent provides the first section of each chromosome. In this way the linkage between sections on a single chromosome was preserved, whilst there was no linkage between chromosomes. Since crossover is performed by selecting a single point per chromosome and then swapping the genetic material on one side of that point between the parents, genes which are close to each other on the chromosome are unlikely to change independently. By ordering the variables and samples in a logical fashion within the chromosomes, one can exploit this linkage to help evolve fitter solutions. In this work, the variables are ordered by chemical shift (p.p.m.), and the samples hierarchically by study, timepoint then dose groups.
Visualization of variable and sample selection
Three different visualizations were used to aid interpretation of the solutions and to gain insight into the working of the GA. The variable frequency visualization shows the number of times each variable is selected. A typical spectrum has been overlaid on a bar chart showing for each variable the number of times over the 50 runs it was selected in the final solutions. The P-values were calculated using the binomial probabilities of variables being selected x times in the 50 independent trials, using the mean selection frequency as the probability of selection in any given trial.
where n = number of trials (50), v = number of variables (205) and m = mean number of times variables are selected, rounded to a whole number (22).
The decision boundary visualization aims to use the information in both the samples and variables selected, and also to illustrate the evolution of the solutions throughout the run of the GA. As the final classification uses a nearest neighbour algorithm, a surface exists dividing two classes. It is not possible to visualize this surface in the full 205-dimensional space, so the selected variables and samples for a particular solution are used as the input for a principal components analysis (PCA) model to reduce this space to two dimensions. The Voronoi surface (Shamos and Hoey, 1975) , which is equidistant from points of each class is shown on the plot.
The sample selection visualization was designed to illustrate which samples were over-selected within a particular solution. Again, the samples were depicted as points in a reduced space, generated by PCA. The PCA plots were generated using all variables and all except two outlying samples. The first two components were used to allow additional information to be overlaid in colour without confusing the plot excessively. This results in plots similar in composition to the information landscape plots seen in springScape (Ebbels et al., 2006) . A Gaussian kernel is centred at each sample, of a height proportional to the number of times that sample was chosen in the final solutions of each run. The colour at each point indicates the sum of the Gaussian densities. The null distribution was estimated by assuming that each point was picked 10 times. This value was obtained from the cumulative binomial distribution above, as the first integer with a P-value below 5%. As for variable selection, the mean frequency of all samples over 50 runs was taken as the estimate of the probability of selection per trial in the null model. The final plot shows the difference between this null distribution and the distribution generated from the real data. Figure 1 shows how the cross-validated performance on the training set improves throughout the GA runs. This clearly shows that performing variable and sample selection simultaneously improves the accuracy of the evolved solutions, to the extent that the average classifier reaches 93.7% accuracy, while the best classifier found achieved 95.7% accuracy on the training set. We compared our simultaneous algorithm with two sequential variants in which 250 generations of variable/sample selection using all variables/samples were followed by 250 generations of sample/variable selection using only the variables/samples chosen by the best solution at the end of the first 250 generations. The simultaneous algorithm showed a much better performance in both cases (Fig. 2) despite the larger number of generations available to the sequential algorithms.
RESULTS AND DISCUSSION
Performance on the training set
In addition to improving the classification accuracy on the training set, simultaneous variable and sample selection also resulted in significantly reduced computation time. Table 2 summarizes the execution times for each algorithm demonstrating a mean improvement of 30.4% per generation, over the next best scenario. Over the course of the run, the percentage of samples and variables selected increased from the initial 10% up to 11.5%. This increase occurs within the first 50 generations. Other trials were performed with the initial selection probability set to 5% and 20%. In the 5% runs, the numbers of selected samples and variables increased throughout but the final solutions performed less well on both classes in the test set. The 20% runs did not show any change in the average number of variables and samples selected, and performed less well on the kidney samples within the test set. These results indicate that there is a minimum complexity of solutions needed to gain good results, and that this complexity is around the 10% level used. Above this level, good solutions can still be found (hence no selection pressure to reduce complexity in the 20% run), however these solutions will be more complex, with little or no gain in performance accuracy.
Performance on independent test set
As with any classification technique the performance on the training set is not a good measure of future performance. A much better measure is the performance obtained on an independent test set. Therefore, the remaining studies were used as such a set. The average accuracy at classifying a whole study from the independent test set was 64.5% for simultaneous variable and samples selection compared with 55.5% and 52.7%, respectively, for variable and sample selection alone. This reflects the exceptional difficulty of this classification problem (Ebbels et al., 2007) . Several factors may lead to a lower classification accuracy than that reported in Ebbels et al. First, these results were obtained using a kNN classifier with k = 1, and this value for k might not be optimal. Second, for some studies there were confounding signals from drug metabolites in the urine, which obscured important spectral regions. Finally, the classifiers featured here, in contrast with those in Ebbels et al. (2007) , gave no measure of confidence in the classification, to indicate when classification may be unreliable.
From a biological perspective, it is interesting to note that some studies were significantly more difficult than others to correctly classify, e.g. acetominophen (Table 3 ). There are many factors which could contribute to the system's poor performance on some of the test set studies. Of those with sub-50% classification rate, all either targeted sites or mechanisms not well represented in the training set (e.g. papillary renal toxicity), or showed relevant lesions in only a small number of the animals. There was also much variation in prediction ability on the kidney studies, suggesting that the urinary biomarkers for nephrotoxicity might be more variable between the different toxins than for hepatotoxicity. This might well be connected to the increased tissue variability seen in the kidney, for instance, markers of cortical and papillary toxicity may be very different.
The effect of the size of the training set was investigated by subsampling the original training set and retraining. The performance on the test set fell proportionally as the training set size decreased, with experiments using just 20% of the training set showing over 10% poorer classification success (see Section 2 and Supplementary Material). Figure 3 highlights the variables that are over-selected by the GA. Many parts of the spectrum are chosen in the best solutions within the range corresponding to random choice. If variables were selected randomly then two variables would be expected above the lower line and none above the higher line. Table 4 lists over-selected variables with P < 0.01 with metabolite assignments. For several metabolites with multiple peaks in the spectrum, more than one peak was over-selected (e.g. 2-oxoglutarate), giving us increased confidence that these metabolites may be important in the classification. Other metabolites have multiple peaks, but only one was frequently selected, probably due to peak overlap making the differences less clear on the other peaks or signal-to-noise limitations which may interfere with lower intensity peaks. The selected metabolites include many compounds known to be associated with hepatotoxicity or nephrotoxicity, for instance increased levels of taurine (selected 11 times, P = 0.015) and creatine (selected 11 times, P = 0.015) have been previously noted as an indicative of hepatotoxicity (Clayton et al., 2003; Waterfield et al., 1993) and a depletion of 2-oxoglutarate probably stems from non-specific consequences of toxicity, for example, reduced food intake. It is important to note that whilst these compounds may not be specific biomarkers of organ toxicity individually, they may provide a discriminatory profile in combination with each other and with other metabolites.
Over-selected variables
Visualization of frequently selected samples
Visualization of sample selection across many solutions is more complex than variable selection. For a single solution it is possible to plot an approximation of the decision boundary (Fig. 4) , by plotting all the samples in a PCA scores plot, then highlighting those which have been selected by the GA. However, since the PCA only approximates the full metabolic space, some points may appear on the wrong side of the boundary even though they are correctly classified in the full space. The evolved solution featured in Figure 4 misclassifies nine samples; however several more points appear to be on the wrong side of the line in this visualization. By viewing these plots for the best solutions from the first and last generations of a run, it is possible to visualize how the sample and variable selection applied by the GA manipulates the space in which the samples are represented, to make the decision surface simpler, and hence the classification more accurate and useful. This process is aided by the fact that GAs optimize solutions by not only increasing accuracy, but also by evolving solutions that are robust to the crossover and mutation operations (Nimwegen et al., 1999) , there by finding simpler solutions which are relatively stable under minor changes. Unlike the variables, the samples showed less of a tendency for a small subset to be selected many times. This can be explained by a redundancy argument. Samples of the same class which have similar profiles will lie close to each other in the metabolic space. Solutions may select any of these samples to represent the classification rule in that region with similar effect and thus the samples are redundant. We therefore propose that both frequency of selection and spatial proximity should be included in the visualization of the sample selection statistics. We developed an approach using a kernel density technique to visualize regions of the metabolic space containing samples which were often selected by the GA (see Section 2). Figure 5 shows the resulting visualization which combines the selection frequency of neighbouring samples with their spatial proximity. Important samples tend to be central to a group of samples of the same type. The colour bar indicates the point below which 95% of the values would be expected to lie under the null hypothesis, and it is clear in that there are several samples or groups of samples which are selected on or over this threshold. Overall this technique and the accompanying visualizations differ significantly from previous work in this area, with the CLOUDS method (Ebbels et al., 2007) . Whereas CLOUDS builds a model incorporating all samples, the approach taken here aimed to build simpler models, with easy interpretability, based only on a subset of samples and variables.
CONCLUSIONS
In summary, this work has shown that GAs providing simultaneous sample and variable selection can perform well at classifying metabonomic toxicology data. Simultaneous variable and sample selection outperformed variable or sample selection use either alone or in sequence, finding solutions more quickly and to an equivalent or higher accuracy rate on an independent validation set. Significantly over-selected variables could be identified which can then be investigated further as possible biomarkers of toxicity. A novel technique for visualization of the samples selected by the GA was developed which combined both frequency of selection and spatial proximity information. Overall, these combined approaches can improve both classification models based on any post-genomic data and also through their interpretation lead to improved biological insights.
